Clinical trial

Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia

NCT00117234

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-09-01

PhaseNA

Study timeline

Study start (unknown)2002-09-01Date precision: month

Registry last updated2010-12-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Congestive Heart Failureunresolved

Anemiaunresolved

Interventions

darbepoetin alfaDRUG · verified · RxNorm: darbepoetin alfa

Sponsors & collaborators

Amgenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00117234 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.